Table 2.
Indications and applications for dedicated breast PET |
---|
Screening in dense breasts, hindering mammography/ultrasound |
Screening in (very) high-risk patients |
Occult lesion on conventional imaging |
Inconclusive lesion on mammography/ultrasound |
Accurate FDG uptake determination in heterogeneous lesions |
Primary tumor response monitoring (in node-negative patients) |
FDG-guided biopsies |
Abbreviations: PET: positron emission tomography, FDG: fluorodeoxyglucose.